# Bioequivalence Minocycline Bioequivalence

> **NCT01755611** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 25 (actual)

## Conditions studied

- Skin Infections (Acne)

## Interventions

- **DRUG:** Minocycline 100mg
- **DRUG:** Minocycline 100mg

## Key facts

- **NCT ID:** NCT01755611
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06-17
- **Primary completion:** 2011-06-25
- **Final completion:** 2011-06-25
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755611, "Bioequivalence Minocycline Bioequivalence". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01755611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*